CAN CREATINE SUPPLEMENTATION IMPROVE PERFORMANCE in ROCK CLIMBERS?

NCT ID: NCT06832423

Last Updated: 2025-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2017-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Why? Bouldering is a form of rock climbing that comprises short rock climbs of approximately three metres in height. Approximately 35,000 people participate in bouldering the UK, 200 of whom do so competitively. Bouldering requires a high strength to body weight ratio. Creatine is widely used in other sports as a nutritional supplement to increase muscle mass, strength and exercise tolerance. Whether Creatine can enhance performance of elite boulderers and in other disciplines of climbing is not known. Answering this question is important to identify safe and legal performance enhancing aids to enable recreational and competitive boulderers and climbers to maximise their personal and competitive potential.

What? This study will investigate a nutritional supplement, Creatine monohydrate (the "active supplement"), and compare its efficacy to a nondistinguishable and similar calorie content supplement, fructose (the "placebo"). Who? Elite boulderers from the Great Britain (GB) Bouldering Team will be invited to take part. If recruitment is slow, highly accomplished climbers from the North Wales region will also be invited.

Where? The study data collection visits will be completed at Bangor University. The supplementation will be completed by the participants at home.

How? The study will utilise a randomised placebo controlled trial design. Randomised means that participants will be allocated to receive the active supplement OR the placebo by chance. The study will last 18 weeks. Participants will visit the University for familiarisation (week 4) and again at baseline (week 0). The tests will include assessment of body weight, a whole body xray scan to determine skeletal muscle mass (at week 0 and 13 only), tests of upper body and core muscle strength, and a test of climbing-specific performance during a simulated bouldering competition.

Then, depending on group allocation, 5 g of the active supplement or placebo will be consumed four times per day for five days (the "loading phase"). Thereafter the dose will be reduced to 3 g once per day for twelve weeks (the "maintenance phase"). The supplement and the placebo will be mixed with flavoured water and consumed at meal and snack times.

Finally, at study cessation (week 13), the University visit will be repeated. The research is being funded by Bangor University. The creatinine and placebo supplements are being supplied by a nutritional company that has no influence over the publication of the results.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rock Climbing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Creatine

5g of the active supplement (creatine monohydrate) will be consumed four times per day for five days (the "loading phase"). Thereafter the dose will be reduced to 3 g once per day for twelve weeks (the "maintenance phase").

Group Type EXPERIMENTAL

Creatine monohydrate

Intervention Type DIETARY_SUPPLEMENT

Powder mixed with flavoured water

Placebo

5g of the placebo supplement (fructose supplement providing the same calorie content as the creatine) will be consumed four times per day for five days (the "loading phase"). Thereafter the dose will be reduced to 3 g once per day for twelve weeks (the "maintenance phase").

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Powder mixed with flavoured water

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Creatine monohydrate

Powder mixed with flavoured water

Intervention Type DIETARY_SUPPLEMENT

Placebo

Powder mixed with flavoured water

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* membership of the GB Bouldering Team or climbing at grade above F6c

Exclusion Criteria

* evident or previously diagnosed kidney damage
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bangor University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bangor University

Bangor, Gwynedd, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15/WA/0438

Identifier Type: OTHER

Identifier Source: secondary_id

creatine01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Creatine and Motor Skill Acquisition
NCT05201651 UNKNOWN EARLY_PHASE1